Neurologist Faked Stroke Data

A University of Wisconsin neuroscientist is found guilty of falsifying Western blots as part of his stroke research, and has requested the retraction of two papers.

By | January 28, 2013

WIKIMEDIA, STEAKPINBALLThe Office of Research Integrity (ORI) has reprimanded Rao M. Adibhatla, a neuroscientist at the University of Wisconsin, Madison, for falsifying experimental results in two published papers and three unfunded grant applications, according to a notice in the Federal Register published last week (January 25).

Investigators found that Adibhatla falsified Western blots representing the expression of particular phospholipids in the brain in a rodent model of stroke. He perpetuated the misconduct by presenting quantifications derived from the falsified Western blots in a bar graphs as the average of replicated Western blots. The ORI concluded that the results “cannot be substantiated by the actually experiments.”

Adibhatla agreed to request the retractions of the two papers in question—one published in 2006 in the Journal of Biological Chemistry, cited 62 times according to ISI Web of Knowledge, and the other in 2007 in Brain Research, cited 33 times.


Add a Comment

Avatar of: You



Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo


Avatar of: Curculio


Posts: 51

January 28, 2013

He should get the Red Foxx award.

Popular Now

  1. Rethinking the Rise of Mammals
    Daily News Rethinking the Rise of Mammals

    Mammals diversified 30 million years later than previously estimated, according to a new analysis of an ancient fossil.

  2. Wiping Out Gut Bugs Stops Obesity
  3. Birth of the Skin Microbiome
    Daily News Birth of the Skin Microbiome

    The immune system tolerates the colonization of commensal bacteria on the skin with the aid of regulatory T cells during the first few weeks of life, a mouse study shows.

  4. Battling the Bulge
    Bio Business Battling the Bulge

    Weight-loss drugs that target newly characterized obesity-related receptors and pathways could finally offer truly effective fat control.

Life Technologies